Effect of an Ultrahigh b Value of 3000 s/mm2 and the Minimal Echo-time on Image Quality and the T2 Shine-through Effect in Diffusion-weighted Imaging of the Liver at 3T: Phantom and Clinical Pilot Studies

Purpose: To assess the effect of an ultrahigh b value of 3000 s/mm2 and the minimal TE of 53 ms on image quality and T2 shine-through effect in liver diffusion-weighted imaging (DWI) using a 3-Tesla MRI scanner with a peak gradient of 100 mT/m. Methods: At b values of 1000 and 3000 s/mm2 and at the minimal (44–53 ms) and routine TEs (70 ms), DWI of our original phantom and liver DWI in 10 healthy volunteers and 26 patients with 35 hepatic hemangiomas were acquired with this scanner, and the quantified SNR of the phantom and the hepatic parenchyma in the volunteers and the contrast-to-noise ratio (CNR) of the hepatic hemangiomas were calculated; two independent readers qualitatively graded the overall image quality in the volunteers and determined the presence or absence of the T2 shine-through effect related to the hemangiomas in the patients. We compared the SNR and subjective overall image quality between the minimal and routine TEs and the CNR and incidence of the T2 shine-through effect between b values of 1000 and 3000 s/mm2. Inter-reader agreement was also evaluated. Results: The SNR at both b values was significantly higher, and the subjective overall image quality at a b value of 3000 s/mm2 was significantly better at the minimal TE than at the routine TE (P < 0.05 for all). The CNR at both TEs and the incidence of the T2 shine-through effect at the minimal TE were significantly lower at a b value of 3000 s/mm2 than at a b value of 1000 s/mm2 (P < 0.05 for all). Inter-reader agreement was excellent. Conclusion: Liver DWI at the ultrahigh b value can reduce the T2 shine-through effect with improvement of image quality using the minimal TE.

[1]  A. Hardie,et al.  Improved differentiation between hepatic hemangioma and metastases on diffusion-weighted MRI by measurement of standard deviation of apparent diffusion coefficient. , 2015, Clinical imaging.

[2]  Steven Conolly,et al.  Improved frequency selective fat suppression in the posterior neck with tissue susceptibility matched pyrolytic graphite foam , 2015, Journal of magnetic resonance imaging : JMRI.

[3]  M. Ronot,et al.  Hepatic hemangiomas: factors associated with T2 shine-through effect on diffusion-weighted MR sequences. , 2014, European journal of radiology.

[4]  Ioannis Lavdas,et al.  A phantom for diffusion‐weighted MRI (DW‐MRI) , 2013, Journal of magnetic resonance imaging : JMRI.

[5]  Takeshi Yoshikawa,et al.  Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.

[6]  A. K. Poyraz,et al.  The role of ADC measurement in differential diagnosis of focal hepatic lesions. , 2012, European journal of radiology.

[7]  Aidos Doskaliyev,et al.  Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. , 2012, European journal of radiology.

[8]  Katarzyna J Macura,et al.  Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[9]  Luca Roccatagliata,et al.  MR diffusion imaging in ischemic stroke. , 2011, Neuroimaging clinics of North America.

[10]  Paul Nikolaidis,et al.  Utility of diffusion‐weighted MRI in distinguishing benign and malignant hepatic lesions , 2010, Journal of magnetic resonance imaging : JMRI.

[11]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[12]  M. Kanematsu,et al.  Diffusion‐weighted imaging of the liver: Optimizing b value for the detection and characterization of benign and malignant hepatic lesions , 2008, Journal of magnetic resonance imaging : JMRI.

[13]  K. Chang,et al.  High b-Value Diffusion (b = 3000 s/mm2) MR Imaging in Cerebral Gliomas at 3T: Visual and Quantitative Comparisons with b = 1000 s/mm2 , 2008, American Journal of Neuroradiology.

[14]  C. Ganter,et al.  Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique , 2008, European Radiology.

[15]  N. Rofsky,et al.  MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. , 2004, Radiology.

[16]  T. Ichikawa,et al.  Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients , 1999, Abdominal Imaging.

[17]  T. Murakami,et al.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease. , 1999, AJR. American journal of roentgenology.

[18]  R. Edelman,et al.  A Phantom for diffusion‐weighted imaging of acute stroke , 1998, Journal of magnetic resonance imaging : JMRI.

[19]  T. Ichikawa,et al.  Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. , 1998, AJR. American journal of roentgenology.

[20]  F. Schmitt,et al.  Initial feasibility studies using single‐shot EPI for the detection of focal liver lesions , 1994, Magnetic resonance in medicine.

[21]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[22]  B. Taouli,et al.  Diffusion-weighted MR imaging of the liver. , 2010, Radiology.